Use of percutaneously inserted venous catheters in coronary care units.
D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001783:Blood Flow Velocity; D002404:Catheterization / Q000009:adverse effects* / Q000295:instrumentation; D002496:Central Venous Pressure; D003325:Coronary Care Units; D005260:Female; D006493:Heparin / Q000008:administration & dosage; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage; D007263:Infusions, Parenteral; D008012:Lidocaine / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011095:Polyethylenes; D011189:Potassium Chloride / Q000009:adverse effects; D011446:Prospective Studies; D013924:Thrombophlebitis / Q000209:etiology; D013997:Time Factors; D014680:Veins
D000900:Anti-Bacterial Agents; D011095:Polyethylenes; D011189:Potassium Chloride; D006493:Heparin; D008012:Lidocaine; D006854:Hydrocortisone